Smith, Molly A.
Choudhary, Gaurav S. http://orcid.org/0000-0001-5365-6706
Pellagatti, Andrea
Choi, Kwangmin
Bolanos, Lyndsey C.
Bhagat, Tushar D.
Gordon-Mitchell, Shanisha
Von Ahrens, Dagny
Pradhan, Kith
Steeples, Violetta
Kim, Sanghyun
Steidl, Ulrich http://orcid.org/0000-0002-9458-1795
Walter, Matthew
Fraser, Iain D. C.
Kulkarni, Aishwarya
Salomonis, Nathan
Komurov, Kakajan http://orcid.org/0000-0003-4834-9845
Boultwood, Jacqueline http://orcid.org/0000-0002-4330-2928
Verma, Amit http://orcid.org/0000-0001-7592-7693
Starczynowski, Daniel T. http://orcid.org/0000-0002-5771-7462
Article History
Received: 17 April 2018
Accepted: 15 March 2019
First Online: 22 April 2019
Competing interests
: A.V. has received research funding from GlaxoSmithKline, Incyte, MedPacto, Novartis, Curis and Eli Lilly and Company, has received compensation as a scientific advisor to Novartis, Stelexis Therapeutics, Acceleron Pharma and Celgene, and has equity ownership in Stelexis Therapeutics.